Reanalysis of the HIV-1 circulating recombinant form A/E (CRF01_AE): evidence of A/E/G recombination.

Circulating recombinant form (CRF) 01_AE caused an extensive HIV-1 epidemic in Thailand and Southeast Asia. Reanalysis of the recombination pattern of CRF01_AE suggested a more complicated pattern of mosaicism consisting of subtypes A, G, and E. These findings provide evidence that CRF01_AE originated from recombination between at least three different subtypes.

[1]  L. Kostrikis,et al.  Re-analysis of human immunodeficiency virus type 1 isolates from Cyprus and Greece, initially designated 'subtype I', reveals a unique complex A/G/H/K/? mosaic pattern. , 2001, The Journal of general virology.

[2]  M. Peeters,et al.  Identification of a complex env subtype E HIV type 1 virus from the democratic republic of congo, recombinant with A, G, H, J, K, and unknown subtypes. , 2000, AIDS research and human retroviruses.

[3]  Allen G. Rodrigo,et al.  Testing the Hypothesis of a Recombinant Origin of Human Immunodeficiency Virus Type 1 Subtype E , 2000, Journal of Virology.

[4]  A. Hatzakis,et al.  Molecular characterization of a recombinant HIV type 1 isolate (A/G/E/?): unidentified regions may be derived from parental subtype E sequences. , 2000, AIDS research and human retroviruses.

[5]  P. Pitisuttithum,et al.  AIDSVAX (MN) in Bangkok injecting drug users: a report on safety and immunogenicity, including macrophage-tropic virus neutralization. , 2000, AIDS research and human retroviruses.

[6]  G. Learn,et al.  HIV-1 Nomenclature Proposal , 2000, Science.

[7]  J. Heeney,et al.  Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine , 1999, Nature Medicine.

[8]  E. Magiorkinis,et al.  Molecular analysis of the full-length genome of HIV type 1 subtype I: evidence of A/G/I recombination. , 1999, AIDS research and human retroviruses.

[9]  J. Yang,et al.  Molecular phylogenetic analysis of human immunodeficiency virus type 1 strains obtained from Korean patients: env gene sequences. , 1999, AIDS research and human retroviruses.

[10]  C. Beyrer,et al.  HIV type 1 subtypes in Malaysia, determined with serologic assays: 1992-1996. , 1998, AIDS research and human retroviruses.

[11]  David L. Robertson,et al.  An Isolate of Human Immunodeficiency Virus Type 1 Originally Classified as Subtype I Represents a Complex Mosaic Comprising Three Different Group M Subtypes (A, G, and I) , 1998, Journal of Virology.

[12]  B. Foley,et al.  Sequence Note: Analysis of Sequence Diversity in the C2–V3 Regions of the External Glycoproteins of HIV Type 1 in Singapore , 1998 .

[13]  J. McNeil,et al.  HIV vaccine development: a subtype E-specific strategy. , 1998, The Southeast Asian journal of tropical medicine and public health.

[14]  C. Beyrer,et al.  The molecular epidemiology of HIV-1 among male sex workers in northern Thailand. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[15]  M. Salminen,et al.  HIV type 1 env gene diversity detected in Taiwan. , 1997, AIDS research and human retroviruses.

[16]  H Hui,et al.  The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin , 1996, Journal of virology.

[17]  D. Gotte,et al.  Full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand , 1996, Journal of virology.

[18]  B. Korber,et al.  Inter- and intraclade neutralization of human immunodeficiency virus type 1: genetic clades do not correspond to neutralization serotypes but partially correspond to gp120 antigenic serotypes , 1996, Journal of virology.

[19]  J. Mascola,et al.  Multiple introductions of HIV-1 subtype E into the western hemisphere , 1995, The Lancet.

[20]  D. Ho,et al.  Genetic analysis of human immunodeficiency virus type 1 strains from patients in Cyprus: identification of a new subtype designated subtype I , 1995, Journal of virology.

[21]  J. Parry,et al.  At least five HIV-1 sequence subtypes (A, B, C, D, A/E) occur in England. , 1995, AIDS research and human retroviruses.

[22]  R. Anderson,et al.  The WHO and why of HIV vaccine trials , 1994, Nature.

[23]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[24]  P. Sharp,et al.  Genetic variation of HIV type 1 in four World Health Organization-sponsored vaccine evaluation sites: generation of functional envelope (glycoprotein 160) clones representative of sequence subtypes A, B, C, and E. WHO Network for HIV Isolation and Characterization. , 1994, AIDS research and human retroviruses.

[25]  S. Vermund,et al.  HIV Vaccine Development: A Progress Report , 1994, Annals of Internal Medicine.

[26]  B. Weniger Experience from HIV incidence cohorts in Thailand: implications for HIV vaccine efficacy trials. , 1994, AIDS.

[27]  Paul Kellam,et al.  Convergent combination therapy can select viable multidrug-resistant HIV-1 in vitro , 1993, Nature.

[28]  D. Celentano,et al.  Risk factors for HIV infection among young adult men in northern Thailand. , 1993, JAMA.

[29]  Rainer Fuchs,et al.  CLUSTAL V: improved software for multiple sequence alignment , 1992, Comput. Appl. Biosci..

[30]  N. Saitou,et al.  The neighbor-joining method: a new method for reconstructing phylogenetic trees. , 1987, Molecular biology and evolution.

[31]  C. Luo,et al.  HIV type 1 subtypes in Guangxi Province, China, 1996. , 1999, AIDS research and human retroviruses.

[32]  Y. Takebe,et al.  The molecular epidemiology of HIV in Asia. , 1994, AIDS.